Home
CYTO
CYTO News

Latest Altamira Therapeutics Ltd. (CYTO) News on July 27, 2024

Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

GlobeNewswire

7 days ago

Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management

GlobeNewswire

a month ago

Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management

Business Wire

2 months ago

Net Asset Value(s)

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Business Wire

2 months ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Business Wire

2 months ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Dstny honored with 'Employee Wellbeing Award'

PR Newswire

2 months ago

Dstny honored with 'Employee Wellbeing Award'

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Newsfile

2 months ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

PR Newswire

2 months ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

GlobeNewswire

2 months ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

GlobeNewswire

2 months ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

2 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

2 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

2 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

2 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Altamira Therapeutics Provides Business Update

GlobeNewswire

2 months ago

Altamira Therapeutics Provides Business Update

Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal

GlobeNewswire

2 months ago

Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

GlobeNewswire

3 months ago

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

GlobeNewswire

3 months ago

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

GlobeNewswire

3 months ago

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on April 18, 2024

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results

GlobeNewswire

4 months ago

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

GlobeNewswire

4 months ago

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

GlobeNewswire

4 months ago

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal

GlobeNewswire

6 months ago

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

PR Newswire

6 months ago

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

GlobeNewswire

6 months ago

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

GlobeNewswire

6 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

$Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient$

GlobeNewswire

6 months ago

Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient

Marpai CEO & Director Acquires 84% More Stock

Simply Wall St.

6 months ago

Marpai CEO & Director Acquires 84% More Stock

Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program

GlobeNewswire

6 months ago

Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program

NETSOL Technologies appoints Jason Hurwitz as Sales Director of Europe

GlobeNewswire

6 months ago

NETSOL Technologies appoints Jason Hurwitz as Sales Director of Europe

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

GlobeNewswire

7 months ago

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

GlobeNewswire

7 months ago

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

LuxUrban Hotels Declares Dividend on 13.00% Series A Cumulative Redeemable Preferred Stock

Business Wire

7 months ago

LuxUrban Hotels Declares Dividend on 13.00% Series A Cumulative Redeemable Preferred Stock

5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex

GlobeNewswire

7 months ago

5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

7 months ago

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

One Cyanotech Insider Raised Stake By 42% In Previous Year

Simply Wall St.

7 months ago

One Cyanotech Insider Raised Stake By 42% In Previous Year

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

Business Wire

7 months ago

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

Business Wire

7 months ago

MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023

Gevo Statement on Treasury Guidance for SAF Tax Credit

GlobeNewswire

7 months ago

Gevo Statement on Treasury Guidance for SAF Tax Credit

Mynaric Receives US $33 million Order from Northrop Grumman

ACCESSWIRE

7 months ago

Mynaric Receives US $33 million Order from Northrop Grumman

Altamira Therapeutics Provides Investor and Business Update

GlobeNewswire

8 months ago

Altamira Therapeutics Provides Investor and Business Update

Business Wire

8 months ago

The Beachbody Company, Inc. Announces $5,300,000 Registered Direct Offering

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

GlobeNewswire

8 months ago

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

Altamira Therapeutics to Host Investor & Business Update Call on December 11th

GlobeNewswire

8 months ago

Altamira Therapeutics to Host Investor & Business Update Call on December 11th

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

GlobeNewswire

8 months ago

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

Eagle Pharmaceuticals Announces Management Change

GlobeNewswire

8 months ago

Eagle Pharmaceuticals Announces Management Change

7 Under-$10 Names to Put in Your Christmas Stocking

InvestorPlace

8 months ago

7 Under-$10 Names to Put in Your Christmas Stocking

BODi Helps End After-Dinner Suffering This Thanksgiving

Business Wire

8 months ago

BODi Helps End After-Dinner Suffering This Thanksgiving

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business

GlobeNewswire

8 months ago

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

GlobeNewswire

8 months ago

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

GlobeNewswire

8 months ago

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine

GlobeNewswire

9 months ago

Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine

Outbrain Inc. (NASDAQ:OB) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Outbrain Inc. (NASDAQ:OB) Q3 2023 Earnings Call Transcript

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results

AlloVir Inc (ALVR) Reports Q3 2023 Financial Results

GuruFocus.com

9 months ago

AlloVir Inc (ALVR) Reports Q3 2023 Financial Results

Share on Social Networks: